Related Experiment Video
Updated: Jun 25, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Thrombolytic therapy for venous thromboembolism: current clinical practice
Gregg J Stashenko1, Charles W Hargett, Victor F Tapson
1Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.
Pulmonologists frequently consider thrombolytic therapy for venous thromboembolism (VTE), especially for massive pulmonary embolism (PE). Despite evolving guidelines, practice patterns remain consistent, highlighting the need for further research and education on VTE treatment.
Area of Science:
- Pulmonary Medicine
- Cardiovascular Medicine
- Critical Care
Background:
- Venous thromboembolism (VTE) is a serious condition where thrombolytic therapy may offer benefits.
- The optimal use of thrombolytic therapy for VTE is debated.
- Previous studies documented practice patterns; this study re-evaluates current use and physician beliefs.
Purpose of the Study:
- To re-evaluate the use of thrombolytic therapy in venous thromboembolism (VTE).
- To assess current practice patterns and physician beliefs regarding thrombolytic therapy for VTE.
- To compare current practices with previous findings in light of updated guidelines.
Main Methods:
- A web-based questionnaire was distributed to active pulmonologists in 11 southeastern states.
- The survey included questions on physician background and hypothetical VTE case scenarios.
- Respondents indicated their likelihood of using thrombolytic therapy in various clinical situations.
Main Results:
- 84% of surveyed pulmonologists reported using thrombolytic therapy for VTE in the past two years.
- 99% would consider thrombolytics for massive pulmonary embolism (PE) with hypotension.
- A majority would consider thrombolytics for PE with severe hypoxemia (83%) or right ventricular dysfunction (62%).
Conclusions:
- Most pulmonologists would consider thrombolytic therapy for massive PE, even with contraindications.
- Physician practices align with previous surveys, indicating limited change despite evolving data.
- Further physician education and randomized trials are necessary to clarify optimal VTE management with thrombolytics.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Pulmonary Embolism III: Nursing Management
